| Quarter | Score |
|---|---|
| 2022-Q1 | 49.8 |
| 2022-Q3 | 43.4 |
| 2022-Q4 | 49.7 |
| 2023-Q1 | 55.3 |
| 2023-Q2 | 65.0 |
| 2023-Q3 | 48.5 |
| 2023-Q4 | 66.1 |
| 2024-Q1 | 49.5 |
| 2024-Q2 | 43.2 |
| 2024-Q3 | 58.0 |
| 2024-Q4 | 58.9 |
| 2025-Q1 | 59.2 |
| 2025-Q2 | 62.6 |
| 2025-Q3 | 62.3 |
| 2025-Q4 | 62.5 |
| 2026-Q1 | 62.4 |
| 2026-Q2 | 79.5 |
High consensus with active accumulation at an attractive valuation
Within 4.6% of funds' estimated purchase price
2 of 18 tracked funds hold BA. Avg conviction: 1.1%. Net holding. First tracked at $184.26 (current +4.6% vs tracked).
Appaloosa Management has 2.2% in this stock
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Appaloosa Management | 2.2% | New Buy |
| Citadel Advisors | 0.0% | Reduce |